Welcome
We are very pleased to announce the Conference on Hematology and Oncology (CoHO) will be taking place on November 13 & 14, 2026.
In the last year, many advancements have been made in oncology and hematology and we are eager to pursue our continued education as it is so crucial to the advancement of treatment for our patients.
Our objective is to provide high quality education and an opportunity to network with our colleagues. CoHO will focus on advancements in Hematology including; Lymphoma, CLL, and Myeloma, and in Oncology including; Breast, Lung, and GI.
Oncologists and hematologists as well as physicians in other disciplines, GPOs, residents, nurse practitioners and pharmacists, will come together in an environment where challenging cases can be discussed, and best practices shared. There will be keynote presentations on new and relevant data followed by panel discussions. At this time facilitators can present a series of interactive case discussions with audience participation. By keeping the program interactive, we will be successful in engaging the audience and enhance learning.
We hope you will be joining us for CoHO!
Sincerely,
Dr. Wendy Lam,
CoHO Chair, Burnaby Hospital Regional Cancer Centre
On behalf of the CoHO Planning Committee
– Dr. Barbara Melosky, BC Cancer
– Dr. Laurie Sehn, BC Cancer
– Dr. Simon Yu, Burnaby Hospital Regional Cancer Centre
CALLING ALL RESIDENTS & FELLOWS
We invite all attendees to present a virtual poster of original research or a case report with literature review (required). Posters presented at other meetings within the past year are acceptable. Abstracts will be due Nov 2nd and the top 3 will be selected for oral presentation to the judges. Poster judging will take place at the CoHO welcome reception on Friday Nov 13th. The prizes for the best research and case report posters will be presented at the meeting on Saturday Nov 14th.
CoHO Fellows and Residents program attendees must also attend the main conference taking place on Fri Nov 13 & Sat Nov 14. (mandatory attendance for both sessions)
SUBMIT YOUR ABSTRACT HERE >>>
Learning Objectives:
- Describe new practice-changing developments in malignant hematology and medical oncology in 2026
- Select the appropriate clinical conditions in oncology and hematology using newly developed 2026 treatments
- Identify risks and benefits of new treatments
- Describe the most important management issues in hematology/oncology and select the best treatments based on current evidence
- Apply best evidence for patient management using case based approach